Sino Biological,Inc. (SHE:301047)
China
· Delayed Price · Currency is CNY 70.94
+0.84 (1.20%)
At close: Apr 29, 2026
Sino Biological,Inc. Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Market Capitalization | 8,527 | 8,223 | 7,523 | 10,646 | 12,876 | 23,508 | Upgrade
|
| Market Cap Growth | 4.22% | 9.30% | -29.33% | -17.32% | -45.23% | - | Upgrade
|
| Enterprise Value | 5,358 | 5,013 | 3,684 | 5,947 | 6,915 | 17,218 | Upgrade
|
| Last Close Price | 70.10 | 67.60 | 57.79 | 74.97 | 88.81 | 157.68 | Upgrade
|
| PE Ratio | 57.71 | 55.66 | 61.70 | 40.93 | 42.50 | 32.65 | Upgrade
|
| Forward PE | 48.34 | 52.81 | 42.22 | 34.41 | 38.78 | 20.76 | Upgrade
|
| PS Ratio | 12.19 | 11.75 | 12.26 | 16.47 | 22.41 | 24.35 | Upgrade
|
| PB Ratio | 1.60 | 1.55 | 1.30 | 1.67 | 2.02 | 3.48 | Upgrade
|
| P/TBV Ratio | 1.71 | 1.65 | 1.38 | 1.67 | 2.02 | 3.48 | Upgrade
|
| P/FCF Ratio | 188.89 | 182.15 | 171.82 | - | 137.95 | 39.53 | Upgrade
|
| P/OCF Ratio | 58.33 | 56.25 | 66.15 | 33.01 | 51.63 | 36.58 | Upgrade
|
| EV/Sales Ratio | 7.66 | 7.17 | 6.00 | 9.20 | 12.04 | 17.84 | Upgrade
|
| EV/EBITDA Ratio | 29.57 | 32.27 | 38.90 | 32.67 | 31.25 | 24.29 | Upgrade
|
| EV/EBIT Ratio | 59.40 | 55.57 | 125.79 | 43.80 | 33.98 | 24.72 | Upgrade
|
| EV/FCF Ratio | 118.69 | 111.05 | 84.15 | - | 74.09 | 28.95 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.30 | 0.30 | 0.56 | 0.42 | 0.29 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 1.19 | 1.19 | 1.54 | - | 0.76 | 0.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.60 | -0.60 | -0.67 | -0.75 | -0.90 | -0.96 | Upgrade
|
| Net Debt / EBITDA Ratio | -20.40 | -20.40 | -40.98 | -26.17 | -25.90 | -9.12 | Upgrade
|
| Net Debt / FCF Ratio | -70.19 | -70.19 | -88.66 | 6.61 | -61.41 | -10.87 | Upgrade
|
| Asset Turnover | 0.12 | 0.12 | 0.10 | 0.10 | 0.09 | 0.23 | Upgrade
|
| Inventory Turnover | 2.65 | 2.65 | 2.92 | 2.52 | 2.63 | 3.54 | Upgrade
|
| Quick Ratio | 22.41 | 22.41 | 20.86 | 36.64 | 47.60 | 67.82 | Upgrade
|
| Current Ratio | 23.03 | 23.03 | 21.30 | 37.17 | 48.12 | 68.30 | Upgrade
|
| Return on Equity (ROE) | 2.67% | 2.67% | 2.01% | 4.08% | 4.62% | 17.89% | Upgrade
|
| Return on Assets (ROA) | 0.97% | 0.97% | 0.29% | 1.29% | 1.89% | 10.42% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.52% | 3.68% | 1.45% | 10.95% | 38.86% | 234.42% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.70% | 1.70% | 0.50% | 2.10% | 3.20% | 10.30% | Upgrade
|
| Earnings Yield | 1.73% | 1.80% | 1.62% | 2.44% | 2.35% | 3.06% | Upgrade
|
| FCF Yield | 0.53% | 0.55% | 0.58% | -6.77% | 0.73% | 2.53% | Upgrade
|
| Dividend Yield | 7.42% | 7.69% | 1.73% | 2.67% | 2.25% | 3.34% | Upgrade
|
| Payout Ratio | 411.67% | 411.67% | 209.57% | 99.33% | 224.45% | - | Upgrade
|
| Buyback Yield / Dilution | 4.93% | 4.93% | 0.97% | -13.44% | -5.79% | -11.11% | Upgrade
|
| Total Shareholder Return | 12.09% | 12.62% | 2.71% | -10.77% | -3.54% | -7.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.